[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368593-105":59,"doc-detail-368593-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","prognostic-and-immunotherapeutic-significance-of-ncapd2-in-pan-cancer-and-its-role-in-hepatocellular-carcinoma-progression-via-the-aktgsk-3-signaling-pathway","Prognostic and immunotherapeutic significance of NCAPD2 in pan-cancer and its role in hepatocellular carcinoma progression via the AKT/GSK-3β signaling pathway","","Study evaluates NCAPD2, a condensin I subunit, across pan-cancer with a focus on hepatocellular carcinoma (HCC), using public databases including TCGA, TIMER2.0, and HPA, alongside experimental assays. NCAPD2 shows aberrant overexpression in multiple cancers, linking to poor prognosis, with associations involving mutations, methylation, and microsatellite instability. In HCC, NCAPD2 correlates with immune cell infiltration and immunotherapy response. Mechanistic tests indicate knockdown suppresses proliferation, causes G0/G1 arrest, promotes apoptosis, and restricts migration through the AKT/GSK-3β axis.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-and-immunotherapeutic-significance-of-ncapd2-in-pan-cancer-and-its-role-in-hepatocellular-carcinoma-progression-via-the-aktgsk-3-signaling-pathway/368593/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-and-immunotherapeutic-significance-of-ncapd2-in-pan-cancer-and-its-role-in-hepatocellular-carcinoma-progression-via-the-aktgsk-3-signaling-pathway/368593.png","ImageObject",300,407,{"name":92,"@type":93},"Bintang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is NCAPD2 and why is it investigated in cancer?","Question",{"text":112,"@type":113},"NCAPD2 is a non-SMC condensin I complex subunit involved in mitotic chromosome assembly and dissociation. Its role across pan-cancer and specific mechanisms in HCC are examined due to limited prior knowledge.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does NCAPD2 relate to prognosis and tumor biology across cancers?",{"text":117,"@type":113},"NCAPD2 is aberrantly expressed in multiple cancers, and its upregulation associates with poor prognosis. It also shows links to mutations, methylation changes, and microsatellite instability.",{"name":119,"@type":110,"acceptedAnswer":120},"What findings connect NCAPD2 with immune infiltration and immunotherapy in HCC?",{"text":121,"@type":113},"In HCC, NCAPD2 expression significantly correlates with immune cell infiltration and with immunotherapy response, suggesting a role in shaping the immune microenvironment.",{"name":123,"@type":110,"acceptedAnswer":124},"How does NCAPD2 mechanistically affect HCC cell behavior?",{"text":125,"@type":113},"NCAPD2 knockdown suppresses HCC cell proliferation, induces G0/G1 phase arrest, and promotes apoptosis. It also reduces migration and modulates the AKT/GSK-3β signaling axis, including changes in phosphorylation and p21 expression.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},368593,1790206730,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPrognostic and immunotherapeutic significance of NCAPD2 in pancancer and its role in hepatocellular carcinoma progression via theAKT/ GSK-3β signaling pathway  \nWenjing Ma2,5, Yao Tian3,5, Wanbo Shen4, Zhengrui Song4, Bo Yang4, DaoshengZhou1􀀍 & Daowen Ye1􀀍  \nPresent studies indicated that NCAPD2 (Non-SMC condensin I complex subunit D2) has emerged asan essential participant of condensin I involved in the mitotic chromosome assembly and dissociation. However, its comprehensive role in pan-cancer and its underlying mechanisms remain underexplored. This study systematically analyzed NCAPD2’s prognostic significance, functional mechanisms, and immune infiltration correlations in pan-cancer, with a focus on hepatocellular carcinoma (HCC). Using databases such as TCGA, TIMER2.0, and HPA, we evaluated NCAPD2’s association with oncogenesis, prognosis, methylation, and immune infiltration. Experimental techniques, including BrdU, Transwell, flow cytometry, RT-qPCR, western blotting, and immunofluorescence, were employed to investigate NCAPD2’s functional role. Results revealed that NCAPD2 is aberrantly expressed in multiple cancers, with upregulation linked to poor prognosis. NCAPD2 mutations, methylation changes, and microsatellite instability were also observed in various cancers. In HCC, NCAPD2 expression correlated significantly with immune cell infiltration and immunotherapy response. Mechanistically, NCAPD2 knockdown suppressed HCC cell proliferation, induced G0/G1 phase arrest, and promoted apoptosis. Additionally, NCAPD2 facilitated liver cancer cell migration and regulated the cell cycle via theAKT/GSK-3β signaling axis. Silencing NCAPD2 inhibited AKT andGSK-3β phosphorylation while upregulating p21 expression. In conclusion, NCAPD2 is a potential diagnostic and prognostic marker in pan-cancer, particularly for HCC. It promotes tumor progression through theAKT/GSK-3β pathway and influences immune infiltration, offering insights for immunotherapy and precision medicine strategies in HCC.  \nKeywords NCAPD2, Pan-cancer, Biomarkers, Immune infiltration, Liver neoplasms, Immunity  \nCancer has the second mortality rate worldwide, which has contributed to the globally prominent public health burden1. Although the overall mortality rates have effectively been controlled, large quantities of tumor patients still experienced therapeutic failure and succumbed to cancer2. The present 5-year overall survival of patients remains unsatisfactory after clinical treatment, including immunotherapy, target therapy, and radiotherapy3. Previous studies showed that tumor mutation burden (TMB), immune cell infiltration and immune checkpoint expression are widely recognized indicators for cancer immunotherapy response4–6. Therefore, due to the limitation of immunotherapy markers, there is dire to excavate novel potential therapeutic methods and targets for immunotherapy.  \nCondensin as the multi-subunits protein complex plays a central role in mitotic chromsome assembly and dissociation7, which could classified to two different condensin complex due to their function, named ascondensin I and condensin II8. The structure maintenance of chromosomes (SMC) protein possess the same pair  \n1Gastroenterology, Quanjiao People’s Hospital, Chuzhou 239599, Anhui, China. 2University of Chinese Academy of Sciences, Beijing 100049, China. 3Qilu Pharmaceutical Co., Ltd, Jinan 250100, China. 4Department of Hepatobiliaryand Pancreatic Surgery, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming 650118, China. 5Wenjing Ma and Yao Tian contributed equally to this work and share first authorship.  \n􀀍 email: [893156252@qq.com](893156252@qq.com); [daowenydw@163.com](daowenydw@163.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nof core subunits, and the three non-SMC subunits of condensinI are NCAPD2, NCAPG and NCAPH9. NC","cbCaipnCTvwydy0F","https://ap.wps.com/l/cbCaipnCTvwydy0F","pdf",6357116,18,"English","# Background and rationale\n# Molecular function of NCAPD2 and cancer relevance\n# Data sources and analytical strategy\n# Experimental validation in hepatocellular carcinoma","[{\"question\":\"What is NCAPD2 and why is it investigated in cancer?\",\"answer\":\"NCAPD2 is a non-SMC condensin I complex subunit involved in mitotic chromosome assembly and dissociation. Its role across pan-cancer and specific mechanisms in HCC are examined due to limited prior knowledge.\"},{\"question\":\"How does NCAPD2 relate to prognosis and tumor biology across cancers?\",\"answer\":\"NCAPD2 is aberrantly expressed in multiple cancers, and its upregulation associates with poor prognosis. It also shows links to mutations, methylation changes, and microsatellite instability.\"},{\"question\":\"What findings connect NCAPD2 with immune infiltration and immunotherapy in HCC?\",\"answer\":\"In HCC, NCAPD2 expression significantly correlates with immune cell infiltration and with immunotherapy response, suggesting a role in shaping the immune microenvironment.\"},{\"question\":\"How does NCAPD2 mechanistically affect HCC cell behavior?\",\"answer\":\"NCAPD2 knockdown suppresses HCC cell proliferation, induces G0/G1 phase arrest, and promotes apoptosis. It also reduces migration and modulates the AKT/GSK-3β signaling axis, including changes in phosphorylation and p21 expression.\"}]","Prognostic and immunotherapeutic significance of NCAPD2 in pan-cancer and its role in hepatocellular carcinoma progression via the AKT/GSK-3β signaling pathway | PDF",1790177646,45,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89017b3297af920782e90ac613b112a6.webp",983,1291,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f636af29750b18b73c7d1ac46eaac4b2.webp",982,1290,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6edd1cfa7ec17dfe8c0fd6f80faf88a6.webp",981,1289,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/290cfdc5cb15a579327c184ecdffca66.webp",980,1287]